These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12857891)

  • 1. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir.
    Lin X; Irwin D; Kanazawa S; Huang L; Romeo J; Yen TS; Peterlin BM
    J Virol; 2003 Aug; 77(15):8227-36. PubMed ID: 12857891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir.
    Pardons M; Cole B; Lambrechts L; van Snippenberg W; Rutsaert S; Noppe Y; De Langhe N; Dhondt A; Vega J; Eyassu F; Nijs E; Van Gulck E; Boden D; Vandekerckhove L
    Nat Commun; 2023 Dec; 14(1):8397. PubMed ID: 38110433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A truncated HIV Tat demonstrates potent and specific latency reversal activity.
    Van Gulck E; Pardons M; Nijs E; Verheyen N; Dockx K; Van Den Eynde C; Battivelli E; Vega J; Florence E; Autran B; Archin NM; Margolis DM; Katlama C; Hamimi C; Van Den Wyngaert I; Eyassu F; Vandekerckhove L; Boden D
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0041723. PubMed ID: 37874295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin.
    Mujtaba S; Zhou MM
    Methods; 2011 Jan; 53(1):97-101. PubMed ID: 20828615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of HIV latency by epigenetic and non-epigenetic mechanisms.
    Mbonye U; Karn J
    Curr HIV Res; 2011 Dec; 9(8):554-67. PubMed ID: 22211660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar compartment supportive of reactivation.
    Kizito F; Nguyen K; Mbonye U; Shukla M; Luttge B; Checkley MA; Agaponova A; Leskov K; Karn J
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2202003121. PubMed ID: 38669184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT2 promotes HIV-1 latency by preventing nucleolar exit and phase separation of Tat into the Super Elongation Complex.
    Jin J; Bai H; Yan H; Deng T; Li T; Xiao R; Fan L; Bai X; Ning H; Liu Z; Zhang K; Wu X; Liang K; Ma P; Gao X; Hu D
    Nat Commun; 2023 Nov; 14(1):7274. PubMed ID: 37949879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tat-dependent conditionally replicating adenoviruses expressing diphtheria toxin A for specifically killing HIV-1-infected cells.
    Ni F; Hu K; Li M; Yang M; Xiao Y; Fu M; Zhu Z; Liu Y; Hu Q
    Mol Ther; 2024 Jul; 32(7):2316-2327. PubMed ID: 38734901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.
    Kutsch O; Benveniste EN; Shaw GM; Levy DN
    J Virol; 2002 Sep; 76(17):8776-86. PubMed ID: 12163598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new BET on the control of HIV latency.
    Karn J
    Cell Cycle; 2013 Feb; 12(4):545-6. PubMed ID: 23370386
    [No Abstract]   [Full Text] [Related]  

  • 11. Stochastic pausing at latent HIV-1 promoters generates transcriptional bursting.
    Tantale K; Garcia-Oliver E; Robert MC; L'Hostis A; Yang Y; Tsanov N; Topno R; Gostan T; Kozulic-Pirher A; Basu-Shrivastava M; Mukherjee K; Slaninova V; Andrau JC; Mueller F; Basyuk E; Radulescu O; Bertrand E
    Nat Commun; 2021 Jul; 12(1):4503. PubMed ID: 34301927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Improved Tat/Rev Induced Limiting Dilution Assay With Enhanced Sensitivity and Breadth of Detection.
    Mehta K; Gohil Y; Mishra S; D'silva A; Amanullah A; Selvam D; Pargain N; Nala N; Sanjeeva GN; Ranga U
    Front Immunol; 2021; 12():715644. PubMed ID: 34421920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise.
    Razooky BS; Weinberger LS
    Methods; 2011 Jan; 53(1):68-77. PubMed ID: 21167940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Tat promotes age-related cognitive, anxiety-like, and antinociceptive impairments in female mice that are moderated by aging and endocrine status.
    Qrareya AN; Mahdi F; Kaufman MJ; Ashpole NM; Paris JJ
    Geroscience; 2021 Feb; 43(1):309-327. PubMed ID: 32940828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Transcription Inhibitor 1E7-03 Decreases Nucleophosmin Phosphorylation.
    Lin X; Ahmad A; Ivanov AI; Simhadri J; Wang S; Kumari N; Ammosova T; Nekhai S
    Mol Cell Proteomics; 2023 Feb; 22(2):100488. PubMed ID: 36563749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximity Ligation Assay to Detect the Proximity Between Host Proteins and Viral Proteins of HIV-1.
    Chakraborty S; Suresh S; Buch H; Panchapakesan A; Ranga U
    Methods Mol Biol; 2024; 2807():245-258. PubMed ID: 38743233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of exosomal HIV-1 Tat expression on the human cellular proteome.
    Lu H; Tang X; Sibley M; Coburn J; Rao RSP; Ahsan N; Ramratnam B
    Oncotarget; 2019 Sep; 10(54):5632-5644. PubMed ID: 31608139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets.
    Raines SLM; Falcinelli SD; Peterson JJ; Van Gulck E; Allard B; Kirchherr J; Vega J; Najera I; Boden D; Archin NM; Margolis DM
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0020124. PubMed ID: 38829049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Expression in Infected T Cell Clones.
    Rausch JW; Parvez S; Pathak S; Capoferri AA; Kearney MF
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of In Vivo Replication Fitness of HIV-1 Variants Resistant to the Tat Inhibitor, dCA.
    Ling L; Leda AR; Begum N; Spagnuolo RA; Wahl A; Garcia JV; Valente ST
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.